Literature DB >> 18691027

Factors controlling chromatin organization and nucleosome positioning for establishment and maintenance of HIV latency.

Ivan Sadowski1, Pedro Lourenco, Tom Malcolm.   

Abstract

Transcription of the integrated HIV provirus is subject to regulation by chromatin organization and must employ host cell transcription factors and chromatin modifying complexes to promote the formation of latency, and then reverse this process to replicate in response to T cell activation. The repressed latent HIV-1 proviral 5' LTR is organized into a defined structure where two de-acetylated and positioned nucleosomes flank the enhancer region, presumably imposing a block to transcriptional initiation and elongation. LTR-associated nucleosomes undergo further histone H3 K9 trimethylation, to cause silencing by recruitment of HP1. In this article, we review current understanding of how the transcriptionally silenced provirus might be established through the function of transcription factors that bind conserved cis-elements, including SP1, YY1, NF-kappaB, CBF-1 and RBF-2 (USF/TFII-I), and propose mechanisms by which factors bound to the repressed LTR can enable reactivation in response to cell signaling.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18691027     DOI: 10.2174/157016208785132563

Source DB:  PubMed          Journal:  Curr HIV Res        ISSN: 1570-162X            Impact factor:   1.581


  22 in total

1.  Identification and functional analysis of a second RBF-2 binding site within the HIV-1 promoter.

Authors:  Matthew S Dahabieh; Marcel Ooms; Tom Malcolm; Viviana Simon; Ivan Sadowski
Journal:  Virology       Date:  2011-08-02       Impact factor: 3.616

2.  Chromatin reassembly factors are involved in transcriptional interference promoting HIV latency.

Authors:  Edurne Gallastegui; Gonzalo Millán-Zambrano; Jean-Michel Terme; Sebastián Chávez; Albert Jordan
Journal:  J Virol       Date:  2011-01-26       Impact factor: 5.103

Review 3.  Therapy for persistent HIV.

Authors:  Kara S Keedy; David M Margolis
Journal:  Trends Pharmacol Sci       Date:  2010-03-05       Impact factor: 14.819

4.  Combinatorial signals from CD28 differentially regulate human immunodeficiency virus transcription in T cells.

Authors:  Malini Natarajan; Avery August; Andrew J Henderson
Journal:  J Biol Chem       Date:  2010-04-05       Impact factor: 5.157

Review 5.  Progress and challenges in the use of latent HIV-1 reactivating agents.

Authors:  Hong-tao Shang; Ji-wei Ding; Shu-ying Yu; Tao Wu; Qiu-li Zhang; Fu-jun Liang
Journal:  Acta Pharmacol Sin       Date:  2015-06-01       Impact factor: 6.150

6.  Sequence insertions in the HIV type 1 subtype C viral promoter predominantly generate an additional NF-κB binding site.

Authors:  Mahesh Bachu; Anil Babu Mukthey; Rajesh V Murali; Narayanaiah Cheedarla; Anita Mahadevan; Susarla K Shankar; Kadappa S Satish; Tapas K Kundu; Udaykumar Ranga
Journal:  AIDS Res Hum Retroviruses       Date:  2012-03-23       Impact factor: 2.205

7.  is-rSNP: a novel technique for in silico regulatory SNP detection.

Authors:  Geoff Macintyre; James Bailey; Izhak Haviv; Adam Kowalczyk
Journal:  Bioinformatics       Date:  2010-09-15       Impact factor: 6.937

8.  HIV promoter integration site primarily modulates transcriptional burst size rather than frequency.

Authors:  Ron Skupsky; John C Burnett; Jonathan E Foley; David V Schaffer; Adam P Arkin
Journal:  PLoS Comput Biol       Date:  2010-09-30       Impact factor: 4.475

9.  Stem-loop binding protein is a multifaceted cellular regulator of HIV-1 replication.

Authors:  Ming Li; Lynne D Tucker; John M Asara; Collins K Cheruiyot; Huafei Lu; Zhijin J Wu; Michael C Newstein; Mark S Dooner; Jennifer Friedman; Michelle A Lally; Bharat Ramratnam
Journal:  J Clin Invest       Date:  2016-07-25       Impact factor: 14.808

10.  Yeast genetic analysis reveals the involvement of chromatin reassembly factors in repressing HIV-1 basal transcription.

Authors:  Manuela Vanti; Edurne Gallastegui; Iñaki Respaldiza; Alfonso Rodríguez-Gil; Fernando Gómez-Herreros; Silvia Jimeno-González; Albert Jordan; Sebastián Chávez
Journal:  PLoS Genet       Date:  2009-01-16       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.